128 related articles for article (PubMed ID: 10784307)
1. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass.
Haraldsson A; Kieler-Jensen N; Wadenvik H; Ricksten SE
Intensive Care Med; 2000 Feb; 26(2):188-94. PubMed ID: 10784307
[TBL] [Abstract][Full Text] [Related]
2. The effects of milrinone on platelets in patients undergoing cardiac surgery.
Kikura M; Lee MK; Safon RA; Bailey JM; Levy JH
Anesth Analg; 1995 Jul; 81(1):44-8. PubMed ID: 7598280
[TBL] [Abstract][Full Text] [Related]
3. Effect of low concentrations of prostacyclin on platelet function in vitro.
van Heerden PV; Gibbs NM; Michalopoulos N
Anaesth Intensive Care; 1997 Aug; 25(4):343-6. PubMed ID: 9288373
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
Jestice HK; Humphreys JE; English TA; Hoggarth CE; Wells FC
Eur J Cardiothorac Surg; 1990; 4(1):40-4. PubMed ID: 2106334
[TBL] [Abstract][Full Text] [Related]
5. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
[TBL] [Abstract][Full Text] [Related]
7. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
8. Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs.
Habler O; Kleen M; Zwissler B; Pusch R; Welte M; Vogelmeier C; Kempter B; Krombach F; Messmer K
Intensive Care Med; 1996 May; 22(5):426-33. PubMed ID: 8796394
[TBL] [Abstract][Full Text] [Related]
9. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study.
Haraldsson A; Kieler-Jensen N; Ricksten SE
J Cardiothorac Vasc Anesth; 1996 Dec; 10(7):864-8. PubMed ID: 8969392
[TBL] [Abstract][Full Text] [Related]
10. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
Takeda H
Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
[TBL] [Abstract][Full Text] [Related]
12. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.
DiSesa VJ; Huval W; Lelcuk S; Jonas R; Maddi R; Lee-Son S; Shemin RJ; Collins JJ; Hechtman HB; Cohn LH
Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516
[TBL] [Abstract][Full Text] [Related]
13. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
[TBL] [Abstract][Full Text] [Related]
14. Effects of cardiopulmonary bypass and inhaled nitric oxide on platelets in children with congenital heart defects.
Breuer J; Leube G; Mayer P; Gebhardt S; Sieverding L; Häberle L; Heinemann M; Apitz J
Eur J Pediatr; 1998 Mar; 157(3):194-201. PubMed ID: 9537485
[TBL] [Abstract][Full Text] [Related]
15. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
van Heerden PV; Barden A; Michalopoulos N; Bulsara MK; Roberts BL
Chest; 2000 Mar; 117(3):819-27. PubMed ID: 10713012
[TBL] [Abstract][Full Text] [Related]
16. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
17. Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass.
Weitzel NS; Weitzel LB; Epperson LE; Karimpour-Ford A; Tran ZV; Seres T
Anaesthesia; 2012 Oct; 67(10):1158-65. PubMed ID: 22809250
[TBL] [Abstract][Full Text] [Related]
18. Description and evaluation of a delivery system for aerosolized prostacyclin.
Siobal MS; Kallet RH; Pittet JF; Warnecke EL; Kraemer RW; Venkayya RV; Tang JF
Respir Care; 2003 Aug; 48(8):742-53. PubMed ID: 12890294
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
